

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.96832231 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.60114889 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.43230142 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.98262012 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.75785342 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.69631229 |
| 7 | glutamate secretion (GO:0014047) | 5.61796932 |
| 8 | vocalization behavior (GO:0071625) | 5.61264812 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.50745328 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33812856 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.05472189 |
| 12 | layer formation in cerebral cortex (GO:0021819) | 4.98521927 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 4.86818378 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.84339634 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 4.82414774 |
| 16 | exploration behavior (GO:0035640) | 4.80129857 |
| 17 | * regulation of synaptic vesicle exocytosis (GO:2000300) | 4.79280065 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.75577482 |
| 19 | protein localization to synapse (GO:0035418) | 4.70810614 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.63883550 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.57171218 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.31072717 |
| 23 | * regulation of synaptic vesicle transport (GO:1902803) | 4.25729747 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.18184474 |
| 25 | proline transport (GO:0015824) | 4.14969160 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.14702316 |
| 27 | amino acid import (GO:0043090) | 4.11588444 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.98610572 |
| 29 | sodium ion export (GO:0071436) | 3.95814576 |
| 30 | positive regulation of membrane potential (GO:0045838) | 3.94345129 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 3.93447379 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.91640755 |
| 33 | long-term memory (GO:0007616) | 3.89592573 |
| 34 | potassium ion homeostasis (GO:0055075) | 3.88687470 |
| 35 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.88259272 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.87574362 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84358167 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 3.83230209 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.83121416 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81069443 |
| 41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.79882143 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.74707741 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.74004828 |
| 44 | regulation of synaptic plasticity (GO:0048167) | 3.70097418 |
| 45 | glutamate receptor signaling pathway (GO:0007215) | 3.66443497 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.65132234 |
| 47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.64864338 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.63208038 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.62938270 |
| 50 | auditory behavior (GO:0031223) | 3.57121027 |
| 51 | neurotransmitter transport (GO:0006836) | 3.55214244 |
| 52 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.54596509 |
| 53 | regulation of postsynaptic membrane potential (GO:0060078) | 3.51513699 |
| 54 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.51097653 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.45532044 |
| 56 | potassium ion import (GO:0010107) | 3.45188441 |
| 57 | prepulse inhibition (GO:0060134) | 3.42976970 |
| 58 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.41879496 |
| 59 | glycine transport (GO:0015816) | 3.40149608 |
| 60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.39039825 |
| 61 | dendritic spine organization (GO:0097061) | 3.38735758 |
| 62 | response to auditory stimulus (GO:0010996) | 3.36862036 |
| 63 | regulation of ARF protein signal transduction (GO:0032012) | 3.36690429 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.36255076 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35496212 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.34429306 |
| 67 | cell communication by electrical coupling (GO:0010644) | 3.33506721 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 3.31737970 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.30818697 |
| 70 | axon ensheathment in central nervous system (GO:0032291) | 3.28889849 |
| 71 | central nervous system myelination (GO:0022010) | 3.28889849 |
| 72 | * regulation of neurotransmitter secretion (GO:0046928) | 3.28536894 |
| 73 | neuron recognition (GO:0008038) | 3.26287910 |
| 74 | vesicle docking involved in exocytosis (GO:0006904) | 3.25754056 |
| 75 | long-term synaptic potentiation (GO:0060291) | 3.24873369 |
| 76 | neuronal ion channel clustering (GO:0045161) | 3.22075483 |
| 77 | regulation of dendritic spine development (GO:0060998) | 3.21605743 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21410736 |
| 79 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.20710278 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19886834 |
| 81 | transmission of nerve impulse (GO:0019226) | 3.18888037 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.16813647 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.16680229 |
| 84 | cellular sodium ion homeostasis (GO:0006883) | 3.15821340 |
| 85 | vesicle transport along microtubule (GO:0047496) | 3.14194862 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 3.13245263 |
| 87 | axonal fasciculation (GO:0007413) | 3.12506388 |
| 88 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.07149012 |
| 89 | cell communication involved in cardiac conduction (GO:0086065) | 3.06875777 |
| 90 | acidic amino acid transport (GO:0015800) | 3.05775586 |
| 91 | * regulation of neurotransmitter transport (GO:0051588) | 3.05075200 |
| 92 | cell differentiation in hindbrain (GO:0021533) | 3.04451078 |
| 93 | membrane hyperpolarization (GO:0060081) | 3.03454428 |
| 94 | positive regulation of dendrite development (GO:1900006) | 3.02268688 |
| 95 | postsynaptic membrane organization (GO:0001941) | 3.01803378 |
| 96 | membrane depolarization (GO:0051899) | 3.01552799 |
| 97 | positive regulation of synaptic transmission (GO:0050806) | 3.00286288 |
| 98 | detection of calcium ion (GO:0005513) | 2.99849645 |
| 99 | neuromuscular process controlling posture (GO:0050884) | 2.99194738 |
| 100 | neuromuscular process (GO:0050905) | 2.98261706 |
| 101 | cell migration in hindbrain (GO:0021535) | 2.97365190 |
| 102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.97131207 |
| 103 | L-amino acid import (GO:0043092) | 2.97126747 |
| 104 | membrane depolarization during action potential (GO:0086010) | 2.96917991 |
| 105 | establishment of synaptic vesicle localization (GO:0097480) | 2.95914890 |
| 106 | synaptic vesicle transport (GO:0048489) | 2.95914890 |
| 107 | learning (GO:0007612) | 2.94752229 |
| 108 | cerebellar Purkinje cell layer development (GO:0021680) | 2.94697721 |
| 109 | neuromuscular synaptic transmission (GO:0007274) | 2.94668093 |
| 110 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.93565117 |
| 111 | establishment of mitochondrion localization (GO:0051654) | 2.93123756 |
| 112 | vesicle docking (GO:0048278) | 2.92566450 |
| 113 | social behavior (GO:0035176) | 2.92540098 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 2.92540098 |
| 115 | * regulation of synaptic transmission (GO:0050804) | 2.91735162 |
| 116 | regulation of dendrite morphogenesis (GO:0048814) | 2.90825873 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.89715743 |
| 118 | innervation (GO:0060384) | 2.89407889 |
| 119 | dopamine receptor signaling pathway (GO:0007212) | 2.88153917 |
| 120 | regulation of female receptivity (GO:0045924) | 2.83797990 |
| 121 | chemosensory behavior (GO:0007635) | 2.82560244 |
| 122 | synaptic transmission (GO:0007268) | 2.80247539 |
| 123 | organelle transport along microtubule (GO:0072384) | 2.79717501 |
| 124 | establishment of nucleus localization (GO:0040023) | 2.79708133 |
| 125 | synapse assembly (GO:0007416) | 2.79079536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.60976579 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04472225 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.02404164 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96352888 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93875249 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82632593 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77852421 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77852421 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76984986 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68892870 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60145180 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57227629 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56172693 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.52280775 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51413897 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.50925613 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42943108 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42017509 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39459997 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38654415 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34042140 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31563380 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24848480 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19714127 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08379757 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98902192 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95820520 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.83771440 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80535802 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72639486 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58736752 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56226151 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54343434 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49917817 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46409648 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45809675 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43905128 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43346640 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41820337 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41495057 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38479833 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33716048 |
| 43 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30925214 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29685116 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26579606 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21651330 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21216285 |
| 48 | AR_19668381_ChIP-Seq_PC3_Human | 1.19375579 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18959766 |
| 50 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18538847 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16977854 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16906725 |
| 53 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16677043 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16036945 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15779742 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13752471 |
| 57 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12440850 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11046480 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11010394 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09668515 |
| 61 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09111167 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08078779 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07415969 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07279974 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.06702277 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06443612 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05360480 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05210862 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05002095 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03998163 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03858695 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03453636 |
| 73 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03234439 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01702837 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00724106 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00491838 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00404017 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98811114 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98513256 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97841117 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96679311 |
| 82 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95730225 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94860631 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94807305 |
| 85 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.94500471 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94358694 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93616620 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93340831 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92988065 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92910117 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92859413 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92171436 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91663407 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91508782 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91384003 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91306134 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91026661 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90732233 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89501425 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88004660 |
| 101 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.86550513 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86252354 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86110021 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85431190 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84778317 |
| 106 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84772409 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84279080 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84198715 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83981857 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83945803 |
| 111 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83883498 |
| 112 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83828488 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83505358 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82393440 |
| 115 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82269354 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.82241163 |
| 117 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82200911 |
| 118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81846967 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81799639 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81606517 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81407374 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81259578 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.81034016 |
| 124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80470286 |
| 125 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80216638 |
| 126 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79974614 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79170904 |
| 128 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79164245 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78920719 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78377833 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78066602 |
| 132 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77952452 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77924824 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73160933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.61757945 |
| 2 | * MP0003635_abnormal_synaptic_transmissio | 4.35172512 |
| 3 | MP0003880_abnormal_central_pattern | 4.24809577 |
| 4 | MP0004270_analgesia | 4.16880181 |
| 5 | MP0002822_catalepsy | 3.60671754 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.47181668 |
| 7 | MP0009745_abnormal_behavioral_response | 3.40914838 |
| 8 | MP0002064_seizures | 3.11746329 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.99219163 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.93550902 |
| 11 | MP0009046_muscle_twitch | 2.85323283 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.73287525 |
| 13 | * MP0002572_abnormal_emotion/affect_behav | 2.66916932 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.41603498 |
| 15 | MP0002272_abnormal_nervous_system | 2.40951746 |
| 16 | * MP0001486_abnormal_startle_reflex | 2.37645227 |
| 17 | MP0004858_abnormal_nervous_system | 2.25585202 |
| 18 | MP0002736_abnormal_nociception_after | 2.11777620 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.10712526 |
| 20 | MP0003329_amyloid_beta_deposits | 2.07078641 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.06118741 |
| 22 | MP0008569_lethality_at_weaning | 2.02522868 |
| 23 | MP0004811_abnormal_neuron_physiology | 2.01596355 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.99291320 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.98205636 |
| 26 | MP0001970_abnormal_pain_threshold | 1.97233315 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.95354012 |
| 28 | MP0000778_abnormal_nervous_system | 1.74693007 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.69691526 |
| 30 | MP0002184_abnormal_innervation | 1.68110866 |
| 31 | MP0003879_abnormal_hair_cell | 1.67681174 |
| 32 | * MP0002557_abnormal_social/conspecific_i | 1.64231880 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.63641176 |
| 34 | MP0004924_abnormal_behavior | 1.63641176 |
| 35 | MP0004885_abnormal_endolymph | 1.62279035 |
| 36 | MP0000955_abnormal_spinal_cord | 1.62012127 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.44166685 |
| 38 | MP0003633_abnormal_nervous_system | 1.42157784 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.40247980 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.39759663 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.32719730 |
| 42 | MP0003075_altered_response_to | 1.29303015 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.28227404 |
| 44 | MP0003283_abnormal_digestive_organ | 1.27542007 |
| 45 | MP0001984_abnormal_olfaction | 1.25527291 |
| 46 | MP0003787_abnormal_imprinting | 1.22443145 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.20606972 |
| 48 | MP0003123_paternal_imprinting | 1.20110364 |
| 49 | MP0003631_nervous_system_phenotype | 1.16535331 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.11875176 |
| 51 | MP0002152_abnormal_brain_morphology | 1.11110080 |
| 52 | MP0001177_atelectasis | 1.06111705 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.04999317 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.02559787 |
| 55 | MP0008872_abnormal_physiological_respon | 1.01410340 |
| 56 | MP0000751_myopathy | 1.00366787 |
| 57 | MP0004147_increased_porphyrin_level | 0.97969058 |
| 58 | MP0002069_abnormal_eating/drinking_beha | 0.97419008 |
| 59 | MP0000013_abnormal_adipose_tissue | 0.96560992 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 0.95109159 |
| 61 | MP0008874_decreased_physiological_sensi | 0.94278165 |
| 62 | MP0000604_amyloidosis | 0.93977255 |
| 63 | MP0001905_abnormal_dopamine_level | 0.92262796 |
| 64 | MP0005623_abnormal_meninges_morphology | 0.88306935 |
| 65 | MP0001529_abnormal_vocalization | 0.87286353 |
| 66 | MP0003690_abnormal_glial_cell | 0.85736325 |
| 67 | MP0004142_abnormal_muscle_tone | 0.83387234 |
| 68 | MP0003634_abnormal_glial_cell | 0.83063004 |
| 69 | MP0002229_neurodegeneration | 0.81668906 |
| 70 | MP0003122_maternal_imprinting | 0.79480807 |
| 71 | MP0003632_abnormal_nervous_system | 0.78619575 |
| 72 | MP0000920_abnormal_myelination | 0.78595673 |
| 73 | MP0004085_abnormal_heartbeat | 0.77600506 |
| 74 | MP0005535_abnormal_body_temperature | 0.77595626 |
| 75 | MP0002090_abnormal_vision | 0.77572869 |
| 76 | MP0002638_abnormal_pupillary_reflex | 0.77103501 |
| 77 | MP0005409_darkened_coat_color | 0.74694783 |
| 78 | MP0005394_taste/olfaction_phenotype | 0.74678504 |
| 79 | MP0005499_abnormal_olfactory_system | 0.74678504 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.70918905 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.69649204 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.66841854 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.65651771 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.65375867 |
| 85 | MP0001664_abnormal_digestion | 0.65117849 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.64592630 |
| 87 | MP0004742_abnormal_vestibular_system | 0.64450556 |
| 88 | MP0004510_myositis | 0.64036838 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.62507993 |
| 90 | MP0004233_abnormal_muscle_weight | 0.62219261 |
| 91 | MP0005187_abnormal_penis_morphology | 0.61939332 |
| 92 | MP0001188_hyperpigmentation | 0.61388596 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.61044443 |
| 94 | MP0000579_abnormal_nail_morphology | 0.59699036 |
| 95 | MP0001299_abnormal_eye_distance/ | 0.59082469 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.58898416 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.58869101 |
| 98 | MP0003861_abnormal_nervous_system | 0.57771972 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.57386100 |
| 100 | MP0005166_decreased_susceptibility_to | 0.56371760 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.56193696 |
| 102 | MP0004130_abnormal_muscle_cell | 0.54596674 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.54488359 |
| 104 | MP0010768_mortality/aging | 0.53916609 |
| 105 | MP0000747_muscle_weakness | 0.53897105 |
| 106 | MP0001943_abnormal_respiration | 0.53317721 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.53100118 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.53030993 |
| 109 | MP0010769_abnormal_survival | 0.51990939 |
| 110 | MP0004484_altered_response_of | 0.51054000 |
| 111 | MP0002082_postnatal_lethality | 0.50175249 |
| 112 | MP0010770_preweaning_lethality | 0.50175249 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.49589453 |
| 114 | MP0003956_abnormal_body_size | 0.49567649 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.47446386 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.47032705 |
| 117 | MP0002873_normal_phenotype | 0.46001255 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.45527899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.60298711 |
| 2 | Focal motor seizures (HP:0011153) | 6.67608416 |
| 3 | Focal seizures (HP:0007359) | 5.43499488 |
| 4 | Visual hallucinations (HP:0002367) | 5.34285983 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.26396664 |
| 6 | Action tremor (HP:0002345) | 4.11673382 |
| 7 | Ankle clonus (HP:0011448) | 4.09007326 |
| 8 | Papilledema (HP:0001085) | 3.85509260 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.79024077 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.77786379 |
| 11 | Atonic seizures (HP:0010819) | 3.75183952 |
| 12 | Febrile seizures (HP:0002373) | 3.61311302 |
| 13 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.53451490 |
| 14 | Poor eye contact (HP:0000817) | 3.52462932 |
| 15 | Absence seizures (HP:0002121) | 3.50956914 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.49114835 |
| 17 | Depression (HP:0000716) | 3.43168555 |
| 18 | Mutism (HP:0002300) | 3.35840249 |
| 19 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.33075267 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.32323372 |
| 21 | Tetraplegia (HP:0002445) | 3.23789637 |
| 22 | Abnormal social behavior (HP:0012433) | 3.21917410 |
| 23 | Impaired social interactions (HP:0000735) | 3.21917410 |
| 24 | Torticollis (HP:0000473) | 3.15584324 |
| 25 | Broad-based gait (HP:0002136) | 3.14796323 |
| 26 | Dialeptic seizures (HP:0011146) | 3.14625472 |
| 27 | Delusions (HP:0000746) | 3.14087303 |
| 28 | Postural instability (HP:0002172) | 3.10868661 |
| 29 | Urinary urgency (HP:0000012) | 3.03186914 |
| 30 | Dysdiadochokinesis (HP:0002075) | 3.01624927 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.99222758 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.95613616 |
| 33 | Cerebral hypomyelination (HP:0006808) | 2.94898178 |
| 34 | Anxiety (HP:0000739) | 2.93900973 |
| 35 | Peripheral hypomyelination (HP:0007182) | 2.91863392 |
| 36 | Ventricular fibrillation (HP:0001663) | 2.88845320 |
| 37 | Dysmetria (HP:0001310) | 2.87967777 |
| 38 | Megalencephaly (HP:0001355) | 2.85970846 |
| 39 | Annular pancreas (HP:0001734) | 2.85882866 |
| 40 | Focal dystonia (HP:0004373) | 2.85837524 |
| 41 | Akinesia (HP:0002304) | 2.81807430 |
| 42 | Genetic anticipation (HP:0003743) | 2.75593151 |
| 43 | Amblyopia (HP:0000646) | 2.72505776 |
| 44 | Intention tremor (HP:0002080) | 2.70323358 |
| 45 | Truncal ataxia (HP:0002078) | 2.69840731 |
| 46 | Spastic gait (HP:0002064) | 2.67461567 |
| 47 | Insomnia (HP:0100785) | 2.66606422 |
| 48 | Impaired smooth pursuit (HP:0007772) | 2.63082379 |
| 49 | Pointed chin (HP:0000307) | 2.62868599 |
| 50 | Stereotypic behavior (HP:0000733) | 2.61999285 |
| 51 | Hemiplegia (HP:0002301) | 2.58278268 |
| 52 | Craniofacial dystonia (HP:0012179) | 2.57562620 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.54067152 |
| 54 | Bundle branch block (HP:0011710) | 2.51902556 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.51442767 |
| 56 | Sleep apnea (HP:0010535) | 2.49481766 |
| 57 | Bradykinesia (HP:0002067) | 2.47920989 |
| 58 | Hyperthyroidism (HP:0000836) | 2.45270773 |
| 59 | Termporal pattern (HP:0011008) | 2.43573528 |
| 60 | Insidious onset (HP:0003587) | 2.43573528 |
| 61 | Obstructive sleep apnea (HP:0002870) | 2.42107423 |
| 62 | Hemiparesis (HP:0001269) | 2.42034837 |
| 63 | Truncus arteriosus (HP:0001660) | 2.37466568 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.32663102 |
| 65 | Dysmetric saccades (HP:0000641) | 2.31873932 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.31651177 |
| 67 | Diplopia (HP:0000651) | 2.31651177 |
| 68 | Ankyloglossia (HP:0010296) | 2.30085068 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.29870638 |
| 70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.29779279 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 2.27074263 |
| 72 | Progressive inability to walk (HP:0002505) | 2.26230927 |
| 73 | Excessive salivation (HP:0003781) | 2.23526937 |
| 74 | Drooling (HP:0002307) | 2.23526937 |
| 75 | Lower limb amyotrophy (HP:0007210) | 2.18697252 |
| 76 | Clonus (HP:0002169) | 2.17936580 |
| 77 | Scanning speech (HP:0002168) | 2.17596155 |
| 78 | Abnormality of the corticospinal tract (HP:0002492) | 2.15419311 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.13318941 |
| 80 | Cholecystitis (HP:0001082) | 2.13318941 |
| 81 | Apathy (HP:0000741) | 2.12880207 |
| 82 | Resting tremor (HP:0002322) | 2.11570538 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.10548583 |
| 84 | Limb dystonia (HP:0002451) | 2.09010352 |
| 85 | Epileptiform EEG discharges (HP:0011182) | 2.08326190 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07652365 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.06775381 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.06775381 |
| 89 | Hypsarrhythmia (HP:0002521) | 2.05008344 |
| 90 | Bowel incontinence (HP:0002607) | 2.04859767 |
| 91 | Sudden death (HP:0001699) | 2.03179067 |
| 92 | Hyperventilation (HP:0002883) | 2.02289663 |
| 93 | Status epilepticus (HP:0002133) | 2.01473244 |
| 94 | Lower limb asymmetry (HP:0100559) | 1.97862036 |
| 95 | Heart block (HP:0012722) | 1.97633963 |
| 96 | Spastic tetraparesis (HP:0001285) | 1.97482450 |
| 97 | Hand muscle atrophy (HP:0009130) | 1.94893629 |
| 98 | Rapidly progressive (HP:0003678) | 1.92091459 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.91685688 |
| 100 | Agitation (HP:0000713) | 1.91138980 |
| 101 | Abnormal large intestine physiology (HP:0012700) | 1.89814294 |
| 102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89603757 |
| 103 | Abnormal EKG (HP:0003115) | 1.88164469 |
| 104 | Hammertoe (HP:0001765) | 1.87290807 |
| 105 | Polyphagia (HP:0002591) | 1.87272692 |
| 106 | Diminished motivation (HP:0000745) | 1.86796429 |
| 107 | Hyperacusis (HP:0010780) | 1.86504896 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.85722881 |
| 109 | Syncope (HP:0001279) | 1.85301930 |
| 110 | Incomplete penetrance (HP:0003829) | 1.85253536 |
| 111 | Abnormal atrioventricular conduction (HP:0005150) | 1.85053151 |
| 112 | Prolonged QT interval (HP:0001657) | 1.84831759 |
| 113 | Inappropriate behavior (HP:0000719) | 1.84339637 |
| 114 | Intellectual disability, profound (HP:0002187) | 1.83479601 |
| 115 | Split foot (HP:0001839) | 1.83380361 |
| 116 | Foot dorsiflexor weakness (HP:0009027) | 1.82630509 |
| 117 | Pheochromocytoma (HP:0002666) | 1.82322884 |
| 118 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82082602 |
| 119 | Rigidity (HP:0002063) | 1.80570343 |
| 120 | Absent speech (HP:0001344) | 1.80292000 |
| 121 | Gait ataxia (HP:0002066) | 1.80062558 |
| 122 | Spinal canal stenosis (HP:0003416) | 1.78586470 |
| 123 | Abnormality of saccadic eye movements (HP:0000570) | 1.75897587 |
| 124 | Abnormality of the periventricular white matter (HP:0002518) | 1.74576184 |
| 125 | Hypoventilation (HP:0002791) | 1.74164474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.52680984 |
| 2 | MAP3K9 | 4.36720881 |
| 3 | NTRK3 | 3.88606567 |
| 4 | MARK1 | 3.42240141 |
| 5 | DAPK2 | 3.12603774 |
| 6 | PRKD3 | 2.88502657 |
| 7 | MINK1 | 2.72116535 |
| 8 | KSR2 | 2.60921075 |
| 9 | PAK6 | 2.59569030 |
| 10 | MAP3K4 | 2.50443083 |
| 11 | CAMKK1 | 2.35384277 |
| 12 | NTRK2 | 2.01477882 |
| 13 | NTRK1 | 1.99018284 |
| 14 | MAP2K7 | 1.88794113 |
| 15 | KSR1 | 1.75244693 |
| 16 | TAOK1 | 1.65299376 |
| 17 | DAPK1 | 1.60806359 |
| 18 | MAP2K4 | 1.58349100 |
| 19 | * CDK5 | 1.54550391 |
| 20 | MAP3K2 | 1.53286681 |
| 21 | TYRO3 | 1.52872826 |
| 22 | RIPK4 | 1.46937469 |
| 23 | STK38 | 1.42747667 |
| 24 | SIK2 | 1.33445499 |
| 25 | MAP3K12 | 1.29853124 |
| 26 | ARAF | 1.24646736 |
| 27 | LATS2 | 1.23370791 |
| 28 | CDK19 | 1.19019048 |
| 29 | PRPF4B | 1.18934228 |
| 30 | GRK5 | 1.18304145 |
| 31 | RIPK1 | 1.13158366 |
| 32 | UHMK1 | 1.12096976 |
| 33 | LMTK2 | 1.11532803 |
| 34 | PLK2 | 1.09909040 |
| 35 | MAPK12 | 1.09052429 |
| 36 | PRKCG | 1.07748584 |
| 37 | MAP3K13 | 1.07567401 |
| 38 | ALK | 1.07476797 |
| 39 | FES | 1.06457449 |
| 40 | MAPK13 | 1.05083955 |
| 41 | PHKG1 | 1.03607391 |
| 42 | PHKG2 | 1.03607391 |
| 43 | RET | 1.02914045 |
| 44 | STK11 | 1.02707927 |
| 45 | CAMKK2 | 1.00490790 |
| 46 | PRKCH | 1.00122887 |
| 47 | CDK15 | 0.97896443 |
| 48 | CDK18 | 0.97759562 |
| 49 | TNIK | 0.95026587 |
| 50 | CAMK1 | 0.92907196 |
| 51 | CDK14 | 0.92028771 |
| 52 | BMPR2 | 0.86842670 |
| 53 | RAF1 | 0.86253250 |
| 54 | CDK11A | 0.86059969 |
| 55 | NEK1 | 0.83153814 |
| 56 | PAK3 | 0.82820963 |
| 57 | MAP3K11 | 0.80164283 |
| 58 | MARK2 | 0.76924248 |
| 59 | PKN1 | 0.76543433 |
| 60 | TRIB3 | 0.76233119 |
| 61 | TESK1 | 0.75710517 |
| 62 | CAMK2G | 0.75707319 |
| 63 | PDK1 | 0.74678096 |
| 64 | SGK223 | 0.74480265 |
| 65 | SGK494 | 0.74480265 |
| 66 | PINK1 | 0.71522902 |
| 67 | PDPK1 | 0.70282750 |
| 68 | CAMK2A | 0.69653824 |
| 69 | PTK2B | 0.69252003 |
| 70 | MAP3K1 | 0.69143078 |
| 71 | BRSK1 | 0.69061819 |
| 72 | SGK3 | 0.65431524 |
| 73 | SCYL2 | 0.63962052 |
| 74 | SGK1 | 0.59718388 |
| 75 | DAPK3 | 0.58929438 |
| 76 | DDR2 | 0.58814712 |
| 77 | CSNK1G2 | 0.57969507 |
| 78 | PNCK | 0.56792882 |
| 79 | PRKCZ | 0.56085206 |
| 80 | DYRK1A | 0.53138456 |
| 81 | BRAF | 0.52330995 |
| 82 | CDC42BPA | 0.51044811 |
| 83 | SGK2 | 0.50938330 |
| 84 | MAP2K1 | 0.50069989 |
| 85 | ROCK2 | 0.49582304 |
| 86 | FYN | 0.49448393 |
| 87 | MAP3K7 | 0.49033870 |
| 88 | DMPK | 0.48940569 |
| 89 | RPS6KA3 | 0.48530132 |
| 90 | PDGFRA | 0.47804652 |
| 91 | CAMK2B | 0.47236623 |
| 92 | CASK | 0.45767504 |
| 93 | CAMK1G | 0.44807121 |
| 94 | CAMK4 | 0.44640024 |
| 95 | ROCK1 | 0.43552313 |
| 96 | PRKG2 | 0.42209984 |
| 97 | ERBB2 | 0.41720210 |
| 98 | RPS6KA2 | 0.41083503 |
| 99 | TNK2 | 0.40588377 |
| 100 | CAMK2D | 0.39296168 |
| 101 | MAPK10 | 0.39246217 |
| 102 | FER | 0.39106636 |
| 103 | ICK | 0.38717300 |
| 104 | OXSR1 | 0.36832949 |
| 105 | TAOK2 | 0.36250109 |
| 106 | JAK2 | 0.35629181 |
| 107 | BMX | 0.35003453 |
| 108 | ERBB3 | 0.34731226 |
| 109 | MAP2K6 | 0.34636958 |
| 110 | CCNB1 | 0.34404569 |
| 111 | FGFR2 | 0.30954203 |
| 112 | LIMK1 | 0.30364086 |
| 113 | NEK6 | 0.30324837 |
| 114 | PKN2 | 0.30067827 |
| 115 | PRKCA | 0.30025297 |
| 116 | PRKD1 | 0.29367906 |
| 117 | WNK1 | 0.29323445 |
| 118 | SRC | 0.28103609 |
| 119 | MAPK4 | 0.27506970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20127197 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90916436 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.89933763 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57932003 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.52459192 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44283913 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.41383907 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34221794 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31132744 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30118143 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.27912361 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10083511 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.08126412 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.00262006 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.97648720 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96046920 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88676599 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76420780 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74406739 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66926814 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61679152 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.55992127 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.55666437 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53811938 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.51999182 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48505855 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.41834536 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40235667 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.37058477 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34038443 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.34030167 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32338720 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30814895 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26891542 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.26064708 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24895850 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21696522 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15098380 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.13591377 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11376681 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.07548785 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03122517 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02704383 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95878278 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93935432 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92944791 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91836566 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89626096 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89542284 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89238493 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86629386 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85303802 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83833890 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81497525 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77577060 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76138595 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75916262 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72508983 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72164546 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71208214 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70681435 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68868012 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.67948071 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67451362 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.65781490 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65678315 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65464956 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65406719 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65059632 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64986858 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63679100 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60937539 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60449264 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59126781 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58274795 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57832190 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55387660 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53816775 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52126483 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52100497 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51924970 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.51708830 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.51444254 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50287077 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47741582 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47544366 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47488666 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.46225209 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45870446 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45395507 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44909950 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42756653 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41571804 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39109723 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39048141 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38951096 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37513719 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37054789 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35719558 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35369655 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35168757 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35032117 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.34698583 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.34680149 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32191734 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31398488 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31080019 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31019437 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25719191 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.23853381 |

